Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine in HBeAg Negative Chronic Hepatitis B
NCT00338780Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine in Chronic Hepatitis B (CHB), sponsored by The Chinese University of Hong Kong. Started Nov 2000; status: completed.
02
Drugs
lamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00338780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338780.